| Emily Ames Morgan, MD | |
|
3181 Sw Sam Jackson Park Rd, Portland, OR 97239-3011 | |
| (503) 494-8211 | |
| Not Available |
| Full Name | Emily Ames Morgan |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 13 Years |
| Location | 3181 Sw Sam Jackson Park Rd, Portland, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619267200 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | MD161169 (Oregon) | Secondary |
| 207R00000X | Internal Medicine | MD161169 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bristol Hospice Oregon, Llc | Clackamas, OR | Hospice |
| Ohsu Hospital And Clinics | Portland, OR | Hospital |
| Mirabella Portland | Portland, OR | Nursing home |
| Holladay Park Plaza | Portland, OR | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oregon Health And Sciences University/university Medical Group | 4880760107 | 1485 |
News Archive
Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry, today announced the launch of two new e-courses, titled Employers and Retail Pharmacy.
Telehealth, the use of TV and computer monitors to deliver healthcare remotely, is proving to be a valuable addition to many practices.
Reata Pharmaceuticals, Inc. has announced that RTA 402 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. RTA 402 is currently being studied in a Phase 1/2 trial in patients with pancreatic cancer, and is also in Phase 2 development for chronic kidney disease.
Scientists at the University of Illinois at Urbana-Champaign have designed a potential roadmap to use a biosynthetic pathway taken from a common microorganism to produce compounds that could serve as precursors to explosives or components in everyday devices such as liquid crystal displays or anti-cancer agents.
› Verified 6 days ago
| Entity Name | University Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376709535 PECOS PAC ID: 4880760107 Enrollment ID: O20080910000013 |
News Archive
Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry, today announced the launch of two new e-courses, titled Employers and Retail Pharmacy.
Telehealth, the use of TV and computer monitors to deliver healthcare remotely, is proving to be a valuable addition to many practices.
Reata Pharmaceuticals, Inc. has announced that RTA 402 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. RTA 402 is currently being studied in a Phase 1/2 trial in patients with pancreatic cancer, and is also in Phase 2 development for chronic kidney disease.
Scientists at the University of Illinois at Urbana-Champaign have designed a potential roadmap to use a biosynthetic pathway taken from a common microorganism to produce compounds that could serve as precursors to explosives or components in everyday devices such as liquid crystal displays or anti-cancer agents.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Ames Morgan, MD 3181 Sw Sam Jackson Park Rd, Portland, OR 97239-3011 Ph: (503) 494-8211 | Emily Ames Morgan, MD 3181 Sw Sam Jackson Park Rd, Portland, OR 97239-3011 Ph: (503) 494-8211 |
News Archive
Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry, today announced the launch of two new e-courses, titled Employers and Retail Pharmacy.
Telehealth, the use of TV and computer monitors to deliver healthcare remotely, is proving to be a valuable addition to many practices.
Reata Pharmaceuticals, Inc. has announced that RTA 402 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. RTA 402 is currently being studied in a Phase 1/2 trial in patients with pancreatic cancer, and is also in Phase 2 development for chronic kidney disease.
Scientists at the University of Illinois at Urbana-Champaign have designed a potential roadmap to use a biosynthetic pathway taken from a common microorganism to produce compounds that could serve as precursors to explosives or components in everyday devices such as liquid crystal displays or anti-cancer agents.
› Verified 6 days ago
Salona Shrestha, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4805 Ne Glisan St, Portland, OR 97213 Phone: 503-215-2392 | |
Dr. Emmanuel Trungtoan Tavan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2800 N Vancouver Ave, Suite 230, Portland, OR 97227 Phone: 503-413-2901 | |
Ginevra Lois Liptan, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6400 Sw Canyon Ct, Ste 100, Portland, OR 97221 Phone: 503-477-9616 Fax: 503-477-9808 | |
Donald Richard Sullivan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Uhn67, Portland, OR 97239 Phone: 503-494-6949 | |
Dr. Victor Nguyen Pham, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9205 Sw Barnes Rd, Portland, OR 97225 Phone: 503-216-2906 | |
Richa Uppal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Sw 13th Ave, Portland, OR 97205 Phone: 503-221-0161 Fax: 503-274-1697 | |
Reem Hasan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Ppv 350, Portland, OR 97239 Phone: 503-494-8562 |